Literature DB >> 23900416

Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.

Laura E Rupprecht1, Elizabeth G Mietlicki-Baase, Derek J Zimmer, Lauren E McGrath, Diana R Olivos, Matthew R Hayes.   

Abstract

Glucagon-like peptide-1 (GLP-1) receptors (GLP-1R) expressed in the nucleus tractus solitarius (NTS) are physiologically required for the control of feeding. Recently, NTS GLP-1R-mediated suppression of feeding was shown to occur via a rapid PKA-induced suppression of AMPK and activation of MAPK signaling. Unknown are the additional intracellular signaling pathways that account for the long-term hypophagic effects of GLP-1R activation. Because cAMP/PKA activity can promote PI3K/PIP3-dependent translocation of Akt to the plasma membrane, we hypothesize that hindbrain GLP-1R-mediated control of feeding involves a PI3K-Akt-dependent pathway. Importantly, the novel evidence presented here challenges the dogmatic view that PI3K phosphorylation results in an obligatory activation of Akt and instead supports a growing body of literature showing that activation of cAMP/PKA can inhibit Akt phosphorylation at the plasma membrane. Behavioral data show that inhibition of hindbrain PI3K activity by a fourth icv administration of LY-294002 (3.07 μg) attenuated the food intake- and body weight-suppressive effects of a fourth icv administration of the GLP-1R agonist exendin-4 (0.3 μg) in rats. Hindbrain administration of triciribine (10 μg), an inhibitor of PIP3-dependent translocation of Akt to the cell membrane, also attenuated the intake-suppressive effects of a fourth icv injection of exendin-4. Immunoblot analyses of ex vivo NTS tissue lysates and in vitro GLP-1R-expressing neurons (GT1-7) support the behavioral findings and show that GLP-1R activation decreases phosphorylation of Akt in a time-dependent fashion. Current data reveal the requirement of PI3K activation, PIP3-dependent translocation of Akt to the plasma membrane, and suppression in phosphorylation of membrane-bound Akt to mediate the food intake-suppressive effects of hindbrain GLP-1R activation.

Entities:  

Keywords:  glucagon-like peptide-1; nucleus tractus solitarius; obesity; phosphatidylinositol-3 kinase; protein kinase B

Mesh:

Substances:

Year:  2013        PMID: 23900416      PMCID: PMC3761195          DOI: 10.1152/ajpendo.00367.2013

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  67 in total

1.  Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

Authors:  P J Larsen; M Tang-Christensen; D S Jessop
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  Glucoreceptors controlling feeding and blood glucose: location in the hindbrain.

Authors:  R C Ritter; P G Slusser; S Stone
Journal:  Science       Date:  1981-07-24       Impact factor: 47.728

3.  PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.

Authors:  L R McMahon; P J Wellman
Journal:  Am J Physiol       Date:  1998-01

4.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line.

Authors:  S A Beak; M M Heath; C J Small; D G Morgan; M A Ghatei; A D Taylor; J C Buckingham; S R Bloom; D M Smith
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

7.  Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation.

Authors:  S R James; C P Downes; R Gigg; S J Grove; A B Holmes; D R Alessi
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.

Authors:  K Meeran; D O'Shea; C M Edwards; M D Turton; M M Heath; I Gunn; S Abusnana; M Rossi; C J Small; A P Goldstone; G M Taylor; D Sunter; J Steere; S J Choi; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

9.  Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.

Authors:  Rafael R Schick; Jens P Zimmermann; Thomas vorm Walde; Volker Schusdziarra
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-06       Impact factor: 3.619

10.  A role for glucagon-like peptide-1 in the central regulation of feeding.

Authors:  M D Turton; D O'Shea; I Gunn; S A Beak; C M Edwards; K Meeran; S J Choi; G M Taylor; M M Heath; P D Lambert; J P Wilding; D M Smith; M A Ghatei; J Herbert; S R Bloom
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

View more
  18 in total

Review 1.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

2.  Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.

Authors:  Jacob D Brown; Danielle McAnally; Jennifer E Ayala; Melissa A Burmeister; Camilo Morfa; Layton Smith; Julio E Ayala
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-27       Impact factor: 3.619

3.  The glucagon-like peptide-1 receptor in the ventromedial hypothalamus reduces short-term food intake in male mice by regulating nutrient sensor activity.

Authors:  Melissa A Burmeister; Jacob D Brown; Jennifer E Ayala; Doris A Stoffers; Darleen A Sandoval; Randy J Seeley; Julio E Ayala
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-08-15       Impact factor: 4.310

4.  Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.

Authors:  Timothy L Ramsey; Mark D Brennan
Journal:  Schizophr Res       Date:  2014-10-18       Impact factor: 4.939

5.  Binge-like palatable food intake in rats reduces preproglucagon in the nucleus tractus solitarius.

Authors:  Ashmita Mukherjee; Avery Hum; Tyler J Gustafson; Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2020-02-13

6.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

Review 7.  Hormonal signaling in the gut.

Authors:  Clémence D Côté; Melika Zadeh-Tahmasebi; Brittany A Rasmussen; Frank A Duca; Tony K T Lam
Journal:  J Biol Chem       Date:  2014-02-27       Impact factor: 5.157

Review 8.  The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

Authors:  Xinfu Guan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

9.  Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.

Authors:  Yan Yang; Alexander A Moghadam; Zachary A Cordner; Nu-Chu Liang; Timothy H Moran
Journal:  Endocrinology       Date:  2014-06-20       Impact factor: 4.736

10.  Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.

Authors:  David J Reiner; Elizabeth G Mietlicki-Baase; Lauren E McGrath; Derek J Zimmer; Kendra K Bence; Gregory L Sousa; Vaibhav R Konanur; Joanna Krawczyk; David H Burk; Scott E Kanoski; Gerlinda E Hermann; Richard C Rogers; Matthew R Hayes
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.